new guidelines on using low-molecular-weight heparins (Lovenox, Fragmin, Innohep)

The American Heart Assoc just released new guidelines on using low-molecular-weight heparins (Lovenox, Fragmin, Innohep).

The bottom line...LMW heparins are now considered FIRST-LINE for prevention and treatment of venous thromboembolism (VTE).

Lovenox (enoxaparin) and Fragmin (dalteparin) can also be used as an alternative to heparin for unstable angina.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote